NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The Torray Fund (Fund) is a
separate series of The Torray Fund (Trust). The Trust is registered under the Investment Company Act of 1940, as amended, as a diversified, open-end management investment company. The Trust is organized as a business trust under
Massachusetts law. The Funds investment objectives are to build investor wealth over extended periods and to minimize shareholder capital gains tax liability by limiting the realization of long and short-term gains. The Fund seeks to meet its
objectives by investing its assets in high quality companies that have a record of increasing sales and earnings, and to hold them as long as their fundamentals remain intact. There can be no assurance that the Funds investment objectives will
be achieved.
The following is a summary of
accounting policies followed by the Fund in the preparation of its financial statements. These policies are in conformity with accounting principles generally accepted in the United States of America.
Securities Valuation
Portfolio
securities for which market quotations are readily available are valued at market value, which is determined by using the last reported sale price, or, if no sales are reported, the last reported bid price. For NASDAQ traded securities, market value
is determined on the basis of the NASDAQ Official Closing Price instead of the last reported sales price. Other assets and securities for which no quotations are readily available or for which Torray LLC (the Advisor) believes do not
reflect market value are valued at fair value as determined in good faith by the Advisor under the supervision of the Board of Trustees (the Board or Trustees) in accordance with the Funds Valuation Procedures.
Short-term obligations having remaining maturities of 60 days or less are valued at amortized cost, which approximates market value.
Fair Value Measurements
Various inputs are used in determining the fair value of investments which are as
follows:
|
|
|
Level 1 quoted prices in active markets for identical securities
|
|
|
|
Level 2 significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk,
etc.)
|
|
|
|
Level 3 significant unobservable inputs (including the Funds own assumptions in determining the fair value of investments)
|
The inputs or methodology used
for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
12
The Torray Fund
NOTES TO FINANCIAL STATEMENTS
(continued)
As of June 30, 2013 (unaudited)
The summary of inputs used to value the Funds
investments as of June 30, 2013 is as follows:
|
|
|
|
|
Valuation Inputs
|
|
|
|
|
|
|
Level 1 Quoted Prices *
|
|
$
|
365,635,776
|
|
Level 2 Other Significant Observable Inputs
|
|
|
|
|
Level 3 Significant Unobservable Inputs
|
|
|
|
|
|
|
|
|
|
Total Market Value of Investments
|
|
$
|
365,635,776
|
|
|
|
|
|
|
|
*
|
Security types and industry classifications as defined in the Schedule of Investments.
|
The Fund had no Level 3 investments during the period and had no transfers between Level 1, Level 2 and Level 3
investments during the reporting period.
Securities Transactions and Investment Income
Securities transactions are recorded on a trade date basis.
Realized gains and losses from securities transactions are recorded on the specific identification basis. Dividend income and distributions to shareholders are recorded on the ex-dividend date. Interest income, including amortization of discount on
short-term investments, and expenses are recorded on the accrual basis.
Federal Income Taxes
The Fund intends to continue to comply with the requirements of the Internal Revenue Code applicable to regulated investment companies and to distribute
all of its taxable income, including any net realized gain on investments to its shareholders. Therefore, no federal income tax provision is required.
Management has analyzed the Funds tax positions taken on federal income tax returns for all open tax years (current and prior three
tax years), and has concluded that no provision for federal income tax is required in the Funds financial statements. The Funds federal and state income and federal excise tax returns for tax years for which the applicable statutes of
limitations have not expired are subject to examination by the Internal Revenue Service and state departments of revenue.
Net Asset Value
The net asset value per share of the Fund is determined daily as of the close of trading on
the New York Stock Exchange by dividing the value of the Funds net assets by the number of shares outstanding.
Use of Estimates
In preparing financial statements in accordance with accounting principles generally
accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial
statements, and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.
13
The Torray Fund
NOTES TO FINANCIAL STATEMENTS
(continued)
As of June 30, 2013 (unaudited)
NOTE 2 SHARES OF BENEFICIAL INTEREST TRANSACTIONS
Transactions in shares of beneficial interest
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended
06/30/13
|
|
|
Year ended
12/31/12
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
Shares issued
|
|
|
51,918
|
|
|
$
|
1,908,802
|
|
|
|
138,694
|
|
|
$
|
4,570,038
|
|
Reinvestments of dividends and distributions
|
|
|
55,635
|
|
|
|
2,103,829
|
|
|
|
133,983
|
|
|
|
4,382,730
|
|
Shares redeemed
|
|
|
(614,494
|
)
|
|
|
(22,224,703
|
)
|
|
|
(1,384,521
|
)
|
|
|
(45,126,799
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(506,941
|
)
|
|
$
|
(18,212,072
|
)
|
|
|
(1,111,844
|
)
|
|
$
|
(36,174,031
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of June 30, 2013, the
Trusts officers, Trustees and affiliated persons and their families directly or indirectly controlled 1,568,895 shares or 16.45% of the Fund.
NOTE 3 INVESTMENT TRANSACTIONS
Purchases and sales of investment securities, other than short-term investments, for the six months ended June 30, 2013, aggregated
$27,251,412 and $47,776,949, respectively.
NOTE
4 MANAGEMENT FEES
Pursuant
to the Management Contract, the Advisor provides investment advisory and administrative services to the Fund. The Fund pays the Advisor a management fee, computed daily and payable monthly at the annual rate of 1.00% of the Funds average daily
net assets. For the six months ended June 30, 2013, the Fund incurred management fees of $1,763,700.
Excluding the management fee, other expenses incurred by the Fund during the six months ended June 30, 2013, totaled $289,467. These
expenses include all costs associated with the Funds operations including transfer agent fees, independent trustees fees ($14,000 per annum and $2,000 for each Board meeting attended per Trustee), dues, fees and expenses of registering
and qualifying the Fund and its shares for distribution, charges of the custodian, auditing and legal expenses, insurance premiums, supplies, postage, expenses of issue or redemption of shares, reports to shareholders and Trustees, expenses of
printing and mailing prospectuses, proxy statements and proxies to existing shareholders, and other miscellaneous expenses.
Certain officers and Trustees of the Fund are also officers and/or shareholders of the Advisor, and are not paid by the Fund for serving
in such capacities.
14
The Torray Fund
NOTES TO FINANCIAL STATEMENTS
(continued)
As of June 30, 2013 (unaudited)
NOTE 5 TAX MATTERS
Distributions to shareholders are determined in accordance
with United States federal income tax regulations, which may differ from accounting principles generally accepted in the United States of America.
The tax character of distributions paid during the year ended December 31, 2012 was as follows:
|
|
|
|
|
Distributions paid from:
|
|
|
|
|
Ordinary income
|
|
$
|
4,689,438
|
|
|
|
|
|
|
|
|
$
|
4,689,438
|
|
|
|
|
|
|
The primary difference
between book and tax basis distributions is differing book and tax treatment of short-term capital gains.
At December 31, 2012, the Fund had net capital loss carry forward for federal income tax purposes of $70,638,491 which is available
to reduce future required distributions of net capital gains to shareholders through 2017.
Under current tax law, capital losses realized after October 31 of a funds fiscal year may be deferred and treated as occurring on the first business day of the following fiscal year for tax
purposes. At December 31, 2012, the Fund had deferred post-October capital losses of $17,463, which will be treated as arising on the first business day of the fiscal year ending December 31, 2013.
The following information is based upon the federal tax basis
of investment securities as of June 30, 2013:
|
|
|
|
|
|
|
Gross unrealized appreciation
|
|
$
|
90,310,994
|
|
|
|
Gross unrealized depreciation
|
|
|
(9,748,972
|
)
|
|
|
|
|
|
|
|
|
|
Net unrealized appreciation
|
|
$
|
80,562,022
|
|
|
|
|
|
|
|
|
|
|
Cost
|
|
$
|
285,073,754
|
|
|
|
|
|
|
|
|
|
|
NOTE 6 COMMITMENTS AND
CONTINGENCIES
The Fund indemnifies its
officers and Trustees for certain liabilities that may arise from their performance of their duties to the Fund. Additionally, in the normal course of business, the Fund enters into contracts that contain a variety of representations and warranties
which provide general indemnifications. The Funds maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Fund that have not yet occurred.
15
The Torray Fund
NOTES TO FINANCIAL STATEMENTS
(continued)
As of June 30, 2013 (unaudited)
NOTE 7 SUBSEQUENT EVENTS
Management has evaluated the impact of all subsequent events
on the Fund through the date these financial statements were issued and has determined that there were no subsequent events requiring recognition or disclosure in the financial statements.
NOTE 8 NEW ACCOUNTING PRONOUNCEMENTS
In June 2013, the Financial Accounting Standards Board (the FASB) issued guidance that creates a
two-tiered approach to assess whether an entity is an investment company. The guidance will also require an investment company to measure noncontrolling ownership interests in other investment companies at fair value and will require additional
disclosures relating to investment company status, any changes thereto and information about financial support provided or contractually required to be provided to any of the investment companys investees. The guidance is effective for
financial statements with fiscal years beginning on or after December 15, 2013 and interim periods within those fiscal years. Management is evaluating the impact of this guidance on the Funds financial statement disclosures.
16
The Torray Fund
PORTFOLIO HOLDINGS, PROXY VOTING AND PROCEDURES
As of June 30, 2013 (unaudited)
The Fund files its complete schedule of portfolio holdings
with the Securities and Exchange Commission (the Commission) for the first and third quarters of each fiscal year on Form N-Q. The Funds Forms N-Q are available on the Commissions website at
http://www.sec.gov
. The
Funds Forms N-Q may be reviewed and copied at the Commission's Public Reference Room in Washington, D.C. Information on the operation of the Commissions Public Reference Room may be obtained by calling 1-800-SEC-0330.
A description of the policies and procedures that the Fund
uses to determine how to vote proxies relating to portfolio securities is available without charge, upon request, by calling 1-800-443-3036; and on the Commissions website at
http://www.sec.gov
.
Information regarding how the Fund voted proxies relating to
portfolio securities is available without charge, upon request, by calling 1-800-443-3036; and on the Commissions website at
http://www.sec.gov
.
17
The Torray Fund
ABOUT YOUR FUNDS EXPENSES
As of June 30, 2013 (unaudited)
We believe it is important for you to understand the impact
of costs on your investment. All mutual funds have operating expenses. As a shareholder of the Fund, you incur ongoing costs, including management fees, and other fund expenses. Operating expenses, which are deducted directly from the Funds
gross income, directly reduce the investment return of the Fund.
A mutual funds expenses are expressed as a percentage of its average net assets. This figure is known as the expense ratio. The following examples are intended to help you understand the ongoing
costs (in dollars) of investing in the Fund and to compare these costs with the ongoing costs of investing in other mutual funds. The examples below are based on an investment of $1,000 made at the beginning of the period shown and held for the
entire period.
The table on the next page
illustrates the Funds cost in two ways:
Actual Fund Return
This section helps you estimate the actual expenses that you paid over the period. The
Ending Account Value shown is derived from the Funds actual return, and the third column shows the operating expenses that would have been paid by an investor who started with $1,000 in the Fund. You may use the information here,
together with the amount invested, to estimate the expenses that you paid over the period.
To do so, simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number given for the Fund under the heading
Expenses Paid During Period on the next page.
Hypothetical 5% Return
This section is intended to help you compare your Funds costs with those of other mutual funds. It assumes that the Fund had an annual return of
5% before expenses, and that the expense ratio is unchanged. In this case, because the return used is not the Funds actual return, the results do not apply to your investment. The example is useful in making comparisons because the Commission
requires all mutual funds to calculate expenses based on a 5% return. You can assess the Funds costs by comparing this hypothetical example with the hypothetical examples that appear in shareholder reports of other funds.
Note that expenses shown in the table are meant to highlight
and help you compare ongoing costs only. The Fund does not charge transactions fees, such as purchase or redemption fees, nor does it carry a sales load.
The calculation assumes no shares were bought or sold during
the period. Your actual costs may have been higher or lower, depending on the amount of your investment and the timing of any purchases or redemptions.
18
The Torray Fund
ABOUT YOUR FUNDS EXPENSES
(continued)
As of June 30, 2013 (unaudited)
More information about the Funds expenses, including recent annual expense ratios, can be found in this report. For additional information on operating expenses and other shareholder costs, please
refer to the Funds prospectus.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning
Account Value
January 1, 2013
|
|
|
Ending
Account Value
June
30, 2013
|
|
|
Expenses Paid
During Period*
|
|
Based on Actual Fund Return
|
|
$
|
1,000.00
|
|
|
$
|
1,169.90
|
|
|
$
|
6.24
|
|
Based on Hypothetical 5% Return
(before expenses)
|
|
$
|
1,000.00
|
|
|
$
|
1,019.04
|
|
|
$
|
5.81
|
|
*
|
|
Expenses are equal to the Funds annualized expense ratio of 1.16% for the period, multiplied by the average account value over the period, multiplied by 181/365
(to reflect the one-half year period).
|
19
TRUSTEES
Carol T.
Crawford
Bruce C. Ellis
William M Lane
Robert P. Moltz
Wayne H. Shaner
INVESTMENT ADVISOR
Torray LLC
OFFICERS
Robert E. Torray
William M Lane
Fred M. Fialco
Nicholas C. Haffenreffer
Barbara C. Warder
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
BBD, LLP
1835
Market Street, 26th Floor
Philadelphia, PA 19103
TRANSFER AGENT
BNY Mellon
Investment Servicing (US) Inc.
4400 Computer Drive
Westborough, MA 01581-1722
LEGAL COUNSEL
Dechert LLP
1900
K Street, N.W.
Washington, DC 20006
Distributed by Foreside Funds Distributors LLC
400 Berwyn Park, 899 Cassatt Road,
Berwyn, PA 19132
Date of first use, August 2013
This report is not authorized for distribution to prospective investors unless preceded or accompanied by a current prospectus. All indices
are unmanaged groupings of stocks that are not available for investment.
The
TORRAY
FUND
SEMI-ANNUAL REPORT
June 30, 2013
The Torray Fund
Suite 750 W
7501 Wisconsin Avenue
Bethesda, Maryland 20814-6519
(301)
493-4600
(800)
443-3036
The Torray Resolute Fund
Letter to Shareholders
July 8, 2013
Dear Fellow Shareholders,
The first half of 2013 frustrated the skeptics. As the post-crisis recovery continued at a measured but steady pace, U.S. equity markets
reclaimed the historic highs of 2007. During this period, your Fund performed well, gaining 10.8% in the first half of the year and 20.9% over the trailing twelve months. The Funds returns modestly underperformed the Russell 1000 Growth
Indexs gains of 11.8% in the first half, but outperformed the benchmarks 17.1% gains over the trailing twelve months. The question on most investors minds is whether recent gains are justified and sustainable. Milestones such as
the record highs inevitably bring out the naysayers, but the backdrop of steadily improving fundamentals provided adequate support for the markets advances. Growth is slow but steady, valuations are reasonable, employment is weak but
improving, and interest rates are rising, but remain low by historic standards. This balanced assessment leads us to the conclusion that current market levels are appropriate and we continue to find exceptional companies to invest in at attractive
prices.
We recently bought shares of FMC Corp.
(FMC), a diversified chemical company with $4 billion in revenues and operations in 21 countries. Approximately half of the companys sales are generated by the Agricultural Products division, with the balance split between the Specialty
and Industrial Chemicals divisions. What distinguishes FMC from other specialty chemical companies is a long-standing record of consistent growth and relatively low economic sensitivity. A disciplined strategy of diversifying the portfolio and
minimizing fixed costs has produced industry-leading earnings and cash flow growth of 20% annually over the past 10 years. We expect the companys focus on product innovation and operating efficiencies will continue to support attractive rates
of growth.
Top contributors for the period
included Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX). The release of positive clinical data on drugs targeting hepatitis C (Gilead) and cystic fibrosis (Vertex) increase the probability of continued profitable growth in the future.
Apple (AAPL) was the largest detractor for the period. While innovation and growth have stalled at Apple, we believe the valuation, profit potential and recent plan to return significant capital to shareholders make Apple a compelling investment. We
are always amazed by the markets tendency to overreact in the short and intermediate term. In this case, we believe investors have mispriced the risks associated with Apple.
1
The Torray Resolute Fund
Letter to Shareholders
(continued)
July 8, 2013
Chairman Bernankes May 22nd comments
contemplating a reduction of the Federal Reserves stimulus program took the market by surprise. Immediately following his remarks, rates on the
10-Year
Treasury bond jumped approximately 50 basis points
and stocks and bonds dropped 5% before recovering. Four-plus years into the recovery, it is easy to forget the Federal Reserve will eventually remove the economys training wheels. The markets response to Bernankes testimony is
curious. On the one hand, a withdrawal of stimulative policy introduces uncertainty. On the other, the Chairmans comments come as a result of continued economic stability and improvement. This should be a source of confidence for the market.
We believe a focus on innovation and value is a far more productive investment strategy than second guessing the Federal Reserves next move. However, the Chairmans statements mark an important turning point as the Federal Reserve
prepares to step back and allow market fundamentals to lead. In this case, the transition is likely to be volatile, but ultimately positive for the economy and your portfolio.
As ever, we appreciate your interest and trust.
|
|
|
|
|
|
|
|
|
Respectfully,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nicholas C. Haffenreffer
|
|
|
|
|
2
The Torray Resolute Fund
PERFORMANCE DATA
As of June 30, 2013 (unaudited)